Form 4 for NEPH NEPHROS INC
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-05 · accession 0001437749-22-005408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-07 | 2022-03-05 | NEPH | Astor Andrew | Pres, CEO, CFO, Dir | M - OptEx | $2.70 | +14.8K | 92.8K | +19% | +$40.0K |
| D | 2022-03-07 | 2022-03-05 | NEPH | Astor Andrew | Pres, CEO, CFO, Dir | M - OptEx | $0.00 | -14.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-05 | M | A | 14,815 | $2.70 | 92,773 | D | — | — | |
| 2 | Derivative | Warrants (right to buy) | 2022-03-05 | M | D | 14,815 | $0.00 | 0 | D | $2.70 · 2017-03-17 to 2022-03-17 | 14,815 Common Stock |